“Characterizing Deep Quality-of-Life Response in the TRuE-V1/TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo”, J of Skin, vol. 10, no. 2, p. s752, Mar. 2026, doi: 10.25251/bpnxm492.